The Clinical Application Evaluation of Antiviral Drug Acyclovir in the Treatment of Herpes Zoster
ZENG Xun-liu
Abstract：Objective:To analyze the clinical value of intravenous Acyclovir in the treatment of herpes zoster.Method:129 patients with herpes zoster admitted to our hospital from February 2011 to December 2013 were selected,they were divided into the intravenous Acyclovir group for 65 cases and the oral Acyclovir group for 64 cases.The clinical effect,pain relief time,blister stop time,scabby time,50%lesions scabby time,skin fade time and VAS score between the two groups were observed and compared.Result:The total effective rate of intravenous Acyclovir group was 92.31%(60/65),it was significantly higher than 73.44%(47/64) of oral Acyclovir group,the pain relief time,blister stop time,scabby time,50%lesions scabby time,skin fade time in intravenous Acyclovir group were significantly shorter than those of oral Acyclovir group,the VAS score of intravenous Acyclovir group was significantly lower than oral Acyclovir group,the differences were statistically significant(P<0.05).Conclusion:Intravenous Acyclovir can effectively treat herpes zoster and control herpes zoster neuralgia,is worthy of clinical application.
Keywords：Herpes zosterAcyclovirIntravenous injection
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 17-18,19 )